TickerGuard
Buy Day today: Good (67) Broad market participation · no major macro event

Ingevity Corp (NGVT)

Basic Materials Specialty Chemicals
73.40 $
+0.4% vs. previous close
Closing price · As of: 3. Aug 2026

Who owns Ingevity Corp (NGVT)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 99.0% of the shares are freely tradable; institutional investors hold 106.8%.

Ownership Structure

Institutional ownership
106.8%
Insiders
0.8%
Float
99.0%
Short % of float
4.8%
Shares Outstanding
34Mio.

Largest Shareholders

Institutions

Institutions NGVT
Name Stake (%) Shares Change (%) Date
BlackRock Inc 15.41 5,297,715 -5.4 03/31/2026
Vanguard Portfolio Management, LLC 6.33 2,176,731 +0.0 03/31/2026
Vanguard Capital Management, LLC 4.60 1,581,871 +0.0 03/31/2026
Wellington Management Company LLP 4.35 1,494,292 -22.2 03/31/2026
State Street Corp 4.24 1,459,235 +1.0 03/31/2026
American Century Companies Inc 4.17 1,432,566 -4.4 03/31/2026
Millennium Management LLC 3.36 1,155,372 +25.2 03/31/2026
Segall Bryant & Hamill 3.23 1,109,048 -9.0 03/31/2026

Funds

Funds NGVT
Name Stake (%) Shares Change (%) Date
iShares Core S&P Small-Cap ETF 6.10 2,121,138 +0.0 07/28/2026
Vanguard Morn Total Stk Mkt Idx Investor 3.19 1,109,993 -1.4 06/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
24. Jul 2026 Platt Phillip John SVP, Chief Financial Officer Other 3,294 73.26 241,318
6. Jul 2026 Fisher Ryan C. SVP, Gen. Counsel & Secretary Other 168 73.86 12,408

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

View all insider transactions →

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?